구기지황탕 투여 후 호전된 경도인지장애 환자 1례에 대한 증례보고
A Case Report of a Patient with Mild Cognitive Impairment Treated with Gugijihwang-tang
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Alzheimer's disease is characterized by progressive, irreversible brain damage and cognitive decline. Although the diagnosis and treatment of the prodromal symptoms of dementia are important, no treatment for mild cognitive impairment has been currently established. Herein, we report the case of an 80-year-old female patient with memory complaints treated with Gugijihwang-tang, a traditional Korean medicine herbal formula, as an add-on medication. Case Presentation: The patient was diagnosed with mild cognitive impairment based on clinical examinations using the Mini-Mental State Examination (MMSE), the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Activities of Daily Living (ADL) Scale, Global Deterioration (GDR) Scale, and Clinical Dementia Rating (CDR) Scale. She was treated with Gugijihwang-tang bis in die for 12 months while continuing her original medications, including 5-mg donepezil and 590-mg acetyl-l-carnitine. The MMSE score in the Korean Version of the CERAD Assessment Packet increased from 21 to 27 during the 12-month treatment period, and the CERAD 2 score increased from 33 to 62. The instrumental ADL scale score improved from 11 to 5. Other clinical examination results also showed improvement. The patient was satisfied and experienced no significant adverse events related to the Gugijihwang-tang treatment. Conclusion: This case suggests that Gugijihwang-tang could be considered as a treatment method for patients with mild cognitive impairment.
Abstract
Objective: Alzheimer's disease is characterized by progressive, irreversible brain damage and cognitive decline. Although the diagnosis and treatment of the prodromal symptoms of dementia are important, no treatment for mild cognitive impairment has been currently established. Herein, we report the case of an 80-year-old female patient with memory complaints treated with Gugijihwang-tang, a traditional Korean medicine herbal formula, as an add-on medication. Case Presentation: The patient was diagnosed with mild cognitive impairment based on clinical examinations using the Mini-Mental State Examination (MMSE), the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Activities of Daily Living (ADL) Scale, Global Deterioration (GDR) Scale, and Clinical Dementia Rating (CDR) Scale. She was treated with Gugijihwang-tang bis in die for 12 months while continuing her original medications, including 5-mg donepezil and 590-mg acetyl-l-carnitine. The MMSE score in the Korean Version of the CERAD Assessment Packet increased from 21 to 27 during the 12-month treatment period, and the CERAD 2 score increased from 33 to 62. The instrumental ADL scale score improved from 11 to 5. Other clinical examination results also showed improvement. The patient was satisfied and experienced no significant adverse events related to the Gugijihwang-tang treatment. Conclusion: This case suggests that Gugijihwang-tang could be considered as a treatment method for patients with mild cognitive impairment.
참고문헌 (18)
- Mucke L, "Alzheimer's disease", Nature, 461(7266), pp.895~897 (2009)
- Dubois B, "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria", Lancet Neurol, 13(6), pp.614~629 (2014)
- Riphagen JM, "Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology", Neurobio Aging, 85, pp.96~103 (2020)
- 이정재, "알츠하이머병의 최신지견", 생물정신의학, 23(2), pp.48~56 (2016), 대한생물정신의학회
- Smith GE, "Definition, course, and outcome of mild cognitive impairment", Aging Neuropsychol Cogn, 3(2), pp.141~147 (1996)
- Petersen RC, "Mild cognitive impairment", CONTINUUM: Lifelong Learning in Neurology, 10(1), pp.9~28 (2004)
- 우수경, "경도인지장애에서 알츠하이머병으로의 이환 예측: 복잡한 일상생활 수행능력의 역할", 노인정신의학, 25(1), pp.1~7 (2021), 대한노인정신의학회[DOI]
- Cooper C, "Treatment for mild cognitive impairment:systematic review", Br J Psychiatry, 203(4), pp.255~264 (2013)
- Jung EY, "The neuroprotective effect of gugijihwang -tang on trimethyltin-induced memory dysfunction in the rat", Evid Based Complement Alternat Med, 2013, pp.542081~ (2013)
- 서영경, "치매, 경도인지장애의 한의진료 현황, 진단 및 치료에 대한 한의사의 인식도 조사 연구 - 한방신경정신과 전문의와 일반의의 차이를 중심으로 -", 동의신경정신과학회지, 28(3), pp.263~274 (2017), 대한한방신경정신과학회
- 주진형, "두 가지 한글판 간이정신상태평가(Mini-Mental State Examination)의 비교 : MMSE-KC와 K-MMSE", 신경정신의학, 44(1), pp.98~104 (2005), 대한신경정신의학회
- 구형모, "일상활동평가-복합(Seoul-Instrumental Activities of Daily Living ; S-IADL)의 신뢰도 및 타당도 연구", 신경정신의학, 43(2), pp.189~199 (2004), 대한신경정신의학회
- Choi SH, "The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15(6), pp.609~615 (2000)
- 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
- 원장원, "치매의 등급척도인 전반적퇴화척도(Global Deterioration Scale)의 등급판정 알고리듬 개발 및 타당도 조사", Annals of geriatric medicine and research, 15(2), pp.80~89 (2011), 대한노인병학회
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale", J Korean Neurol Assoc, 19(6), pp.585~591 (2001)
- Korean society of oriental neuropsychiatry, "Korean Medicine Clinical Practice Guideline for Dementia", Guideline center for Korean Medicine, ~ (2017)
- Lee SG, "Effect of Samultang and Yukmizihwangtang on Osteoporosis induced by Ovariectomy of the Rats", J of Jaehan Oriental Medical Academy, 1(1), pp.31~48 (1995)